EDITAS MEDICINE INC (EDIT) Stock Analyst Earnings Estimates
NASDAQ:EDIT - Nasdaq - US28106W1036 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25.54M -71.85% | 19.71M -22.83% | 78.123M 296.36% | 32.846M -57.96% | 8.486M -74.16% | 9.429M 11.11% | 59.868M 534.93% | 46.349M -22.58% | 70.472M 52.05% | 127.79M 81.33% | 219.07M 71.43% | 279.13M 27.42% | |
| EBITDA YoY % growth | -188.1M -43.72% | -219.61M -16.75% | -163.117M 25.72% | -219.678M -34.68% | -114.984M 47.66% | -120.679M -4.95% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -193.15M -43.24% | -225.95M -16.98% | -169.181M 25.12% | -244.665M -44.62% | -157.343M 35.69% | -158.029M -0.44% | -252.64M -59.87% | -204.978M 18.87% | -193.657M 5.52% | -170.607M 11.90% | -140.541M 17.62% | -97.802M 30.41% | |
| Operating Margin | -756.26% | -1,146.37% | -216.56% | -744.89% | -1,854.15% | -1,675.99% | -421.99% | -442.25% | -274.80% | -133.51% | -64.15% | -35.04% | |
| EPS YoY % growth | -2.85 -42.50% | -3.21 -12.63% | -2.05 36.14% | -2.73 -33.30% | -1.49 45.53% | -1.36 8.42% | -2.02 -48.01% | -1.47 27.03% | -1.29 12.70% | -1.07 16.93% | -0.87 18.15% | -0.61 29.96% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 -58.19% | -0.52 31.02% | -0.39 51.97% | -0.35 53.82% | -0.38 -4.93% | -0.43 18.29% | -0.43 -8.77% | -0.43 -23.69% | -0.08 78.63% |
| Revenue Q2Q % growth | 32.875M -45.25% | 951.997K -16.12% | 951.997K 85.57% | 1.122M 1,739.34% | 2.074M -93.69% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -9.191M 48.65% | -62.529M 4.66% | -48.57M 29.68% | -36.725M 40.03% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.067M -42.17% | -51.666M 22.88% | -42.046M 41.52% | -36.89M 43.82% | -33.177M 2.61% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.75 -36.36% | -0.76 | 0.01 | 1.53% |
| Q2 2024 Q2Q % growth | -0.82 -46.43% | -0.72 | -0.10 | -14.27% |
| Q1 2024 Q2Q % growth | -0.76 -7.04% | -0.68 | -0.08 | -12.10% |
| Q4 2023 Q2Q % growth | -0.23 73.86% | -0.55 | 0.32 | 58.41% |
| Q3 2023 Q2Q % growth | -0.55 32.10% | -0.58 | 0.03 | 5.09% |
| Q2 2023 Q2Q % growth | -0.56 28.21% | -0.78 | 0.22 | 28.06% |
| Q1 2023 Q2Q % growth | -0.71 4.05% | -0.80 | 0.09 | 11.21% |
| Q4 2022 Q2Q % growth | -0.88 -44.26% | -0.82 | -0.06 | -7.53% |
| Q3 2022 Q2Q % growth | -0.81 -42.11% | -0.89 | 0.08 | 8.60% |
| Q2 2022 Q2Q % growth | -0.78 3.70% | -0.84 | 0.06 | 6.94% |
| Q1 2022 Q2Q % growth | -0.74 13.95% | -0.81 | 0.07 | 8.76% |
| Q4 2021 Q2Q % growth | -0.61 39.00% | -0.74 | 0.13 | 17.05% |
| Q3 2021 Q2Q % growth | -0.57 -575.00% | -0.83 | 0.26 | 31.53% |
| Q2 2021 Q2Q % growth | -0.81 -88.37% | -0.84 | 0.03 | 3.98% |
| Q1 2021 Q2Q % growth | -0.86 -24.64% | -0.75 | -0.11 | -14.81% |
| Q4 2020 Q2Q % growth | -1.00 -35.14% | -0.75 | -0.25 | -33.14% |
| Q3 2020 Q2Q % growth | 0.12 118.18% | -0.65 | 0.77 | 118.50% |
| Q2 2020 Q2Q % growth | -0.43 37.68% | -0.82 | 0.39 | 47.74% |
| Q1 2020 Q2Q % growth | -0.69 -15.00% | -0.80 | 0.11 | 14.06% |
| Q4 2019 Q2Q % growth | -0.74 | -0.11 | -0.63 | -593.12% |
| Q3 2019 Q2Q % growth | -0.66 | -0.74 | 0.08 | 10.69% |
| Q2 2019 Q2Q % growth | -0.69 | -0.64 | -0.05 | -8.02% |
| Q1 2019 Q2Q % growth | -0.60 | -0.60 | 0.00 | 0.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 61K -98.86% | 2.289M | -2.228M | -97.34% |
| Q2 2024 Q2Q % growth | 513K -82.23% | 5.185M | -4.672M | -90.11% |
| Q1 2024 Q2Q % growth | 1.135M -88.48% | 8.063M | -6.928M | -85.92% |
| Q4 2023 Q2Q % growth | 60.048M 818.17% | 8.102M | 51.946M | 641.15% |
| Q3 2023 Q2Q % growth | 5.336M 13,240.00% | 3.488M | 1.848M | 52.98% |
| Q2 2023 Q2Q % growth | 2.887M -54.61% | 4.254M | -1.367M | -32.13% |
| Q1 2023 Q2Q % growth | 9.851M 45.51% | 3.068M | 6.783M | 221.09% |
| Q4 2022 Q2Q % growth | 6.54M -47.55% | 3.323M | 3.217M | 96.81% |
| Q3 2022 Q2Q % growth | 40K -99.35% | 4.801M | -4.761M | -99.17% |
| Q2 2022 Q2Q % growth | 6.36M 1,573.68% | 4.376M | 1.984M | 45.34% |
| Q1 2022 Q2Q % growth | 6.77M 4.15% | 3.93M | 2.84M | 72.26% |
| Q4 2021 Q2Q % growth | 12.47M 9.19% | 4.372M | 8.098M | 185.22% |
| Q3 2021 Q2Q % growth | 6.2M -90.13% | 4.872M | 1.328M | 27.26% |
| Q2 2021 Q2Q % growth | 380K -96.47% | 6.299M | -5.919M | -93.97% |
| Q1 2021 Q2Q % growth | 6.5M 13.64% | 5.891M | 609K | 10.34% |
| Q4 2020 Q2Q % growth | 11.42M -7.00% | 5.756M | 5.664M | 98.40% |
| Q3 2020 Q2Q % growth | 62.84M 1,532.21% | 6.732M | 56.108M | 833.45% |
| Q2 2020 Q2Q % growth | 10.75M 361.37% | 6.462M | 4.288M | 66.36% |
| Q1 2020 Q2Q % growth | 5.72M 176.33% | 6.86M | -1.14M | -16.62% |
| Q4 2019 Q2Q % growth | 12.28M | 45.507M | -33.227M | -73.02% |
| Q3 2019 Q2Q % growth | 3.85M | 4.811M | -961K | -19.98% |
| Q2 2019 Q2Q % growth | 2.33M | 6.018M | -3.688M | -61.28% |
| Q1 2019 Q2Q % growth | 2.07M | 6.477M | -4.407M | -68.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 18.33% | 23.54% | 2.82% | 2.67% |
| Revenue | 4.87% | 12.1% | -4.89% | -6.75% |